Abstract
Accurate evaluation of coronary artery pathology is essential for risk stratification and tailoring appropriate treatment. Intravascular imaging was introduced for this purpose 40 years ago enabling for the first time in vivo plaque characterization. Since then, several studies have evaluated the efficacy of the existing intravascular imaging modalities in assessing plaque pathology and composition and their potential in guiding intervention and predicting vulnerable plaques. Today it is known that intravascular imaging is an indispensable tool in percutaneous coronary intervention planning, but the existing modalities have a limited efficacy in predicting lesion vulnerability; a fact that should be attributed to their advantages and limitations in accurately assessing morpho-pathological features that are common in advanced atherosclerotic plaques. This review aims to provide a comprehensive evaluation of the performance of intravascular imaging in characterizing plaque phenotypes using histology as a reference standard; it summarizes the studies comparing the available invasive imaging techniques against histology, discusses the findings and limitations of these studies and highlights the potential of novel intravascular imaging approaches that were introduced for a more complete and comprehensive evaluation of plaque pathobiology.
Introduction
Andreas Grüntzig not only introduced percutaneous coronary intervention (PCI) establishing a less invasive alternative for treating coronary artery disease but also showed the feasibility of the in vivo instrumentation of the coronary arteries with pressure catheters to measure vessel physiology (1). His pioneering work inspired engineers towards the development of intravascular catheters that allow real-time evaluation of plaque pathology and physiology enabling a better understanding of atherosclerotic evolution. Yock, taking advantage of his previous research experience in the navy, was the first that built an invasive coronary imaging modality—i.e., the intravascular ultrasound (IVUS)—that provided in vivo assessment of plaque characteristics (2). The preliminary applications of IVUS in clinical practice generated hopes that invasive imaging would be able to detect vulnerable plaques and guide therapy in patients with obstructive coronary artery disease and drive research and industry towards the development of alternative invasive imaging modalities that could provide additional information about plaque morphology. Optical coherence tomography (OCT) was introduced a decade after the first applications of IVUS and near-infrared spectroscopy (NIRS) combined with IVUS a decade later to allow for the first time in vivo detection of plaque burden and biochemical composition.
These three modalities have been extensively used in the clinical practice and research to evaluate atheroma characteristics and optimise treatment planning and today there is robust evidence that support its routine use in complex PCI to reduce major adverse cardiac events (MACE) (3–5). Conversely, studies that have explored the value of IVUS, OCT and NIRS-IVUS to detect vulnerable lesions have demonstrated that these modalities can detect plaques that are prone to progress and cause events, however, with a limited accuracy and a positive predictive value that is <20% casting doubts about their value in risk stratification and vulnerable plaque detection (6). The limited efficacy of invasive imaging to predict atherosclerotic disease progression has been attributed to the complex pathophysiology of the disease that is regulated by systemic factors, the coagulation properties of the blood, local factors such as the distribution of the haemodynamic forces, and also to the fact that invasive imaging has limitations in accurately detecting specific morphological features that are seen in vulnerable plaques (7). The latter factor has driven research towards the design of advanced multimodality imaging catheters for a more comprehensive and complete evaluation of atheroma phenotypes.
This review paper aims to provide an overview of the histology studies that examined the performance of IVUS, OCT, and NIRS-IVUS in characterising plaque pathology, present the novel invasive imaging technologies introduced to overcome the limitations of the first intravascular imaging catheters, and summarize the results of preliminary histology studies that tested the performance of these approaches in detecting plaque features associated with increased vulnerability.
Intravascular ultrasound imaging
Grayscale intravascular ultrasound
The ability of IVUS to assess atherosclerotic disease severity and quantify the lumen and plaque dimensions became apparent from the first validation studies comparing the estimations of this modality against histology (8). However, the performance of IVUS to accurately characterise plaque composition and detect the presence of lipid tissue has been questioned. Preliminary reports have shown that the intensity of the ultrasound signal within the plaque provides information about tissue composition with areas of grayscale intensity lower than that of the adventitia corresponding to lipid tissue, those with areas similar to that of the adventitia to fibrotic, and those with higher than that of the adventitia and acoustic shadowing behind corresponding to calcific tissue (Figures 1, 2) (9). This tissue characterization approach has been incorporated into a user-friendly software called echogenicity, that allows automated characterization of plaque composition based on the grayscale intensity of the pixels constituting the plaque. A histology study in pigs has shown that this approach enables accurate characterization of the plaque composition however the first validation in cadaveric human hearts cast doubts about its efficacy in detecting plaque components (10, 11).
Figure 1
Ideal standalone and hybrid intravascular imaging modality for assessing plaque characteristics using histology as reference standard. Modalities with good performance in detecting a specific plaque feature are indicated with dark red and those with moderate performance with a bright red colour. Photoacoustic image of necrotic core courtesy of Jansen et al. (10.1016/j.pacs.2013.11.003). OCT-NIRS image of thin fibrous cap courtesy of Ali et al. (10.1016/j.jscai.2024.101344). OCT-NIRF image of macrophages and cholesterol crystals, FLIm-OCT image of thin fibrous cap, IVPA-IVUS image of neovessels, NIRS-IVUS OCT-NIRS and IVPA-IVUS images of necrotic core courtesy of Tufaro et al. (10.1016/j.jcin.2024.07.007).
Figure 2
Case examples showing a fibrotic, calcific and lipid-rich plaque on IVUS and OCT images and the corresponding histological sections stained with haematoxylin and eosin. Calcific plaque on IVUS and OCT is indicated by red asterisks and lipid on IVUS and OCT is indicated by yellow asterisks.
More recent studies, however, have provided evidence supporting the validity of pixel intensity in characterizing plaque types. A report including 2,294 IVUS frames matched with histology showed that the presence of echo-lucent plaques (defined as plaques with a pixel intensity smaller than that of the adventitia) and of attenuated plaque (defined as plaques with signal attenuation without the presence of calcific tissue) was associated with the presence of a necrotic core on histology. However, these features had limited efficacy in detecting a necrotic core with a low sensitivity (56.2% for the attenuated plaques and 20.5% for the echolucent plaques) but a high specificity (94.7% for the attenuated plaques and 90.4% for the echolucent plaques) (Table 1) (12).
Table 1
| Study | Objectives | Sample size | Results |
|---|---|---|---|
| Greyscale IVUS | |||
| Gussenhoven et al. (8) | To examine the ability of 40 MHz IVUS imaging to assess plaque composition | 11 human arterial segments form carotid and iliac arteries were studied and diseased section was analysed |
|
| Palmer et al. (84) | To examine the reproducibility and the agreement between IVUS and histology for plaque composition | 50 cross-sections selected from 30 human coronary arteries were analysed |
|
| Pu et al. (12) | To examine the association between specific morphological characteristics on IVUS (echo attenuation, and intraplaque echo-lucent zones) and plaque composition in histology | 2,294 artery segments, 2 mm in size, from 151 human coronary arteries underwent IVUS, NIRS imaging and histological analysis |
|
| OCT | |||
| Plaque composition | |||
| Yabushita et al. (26) | To establish objective image criteria for characterizing plaque composition in OCT using histology as a reference standard | 357 matched OCT and histology cross-sections from the coronary, carotid arteries and the aortas were included in the study; 50 were used for training and 307 for testing |
|
| Kawasaki et al. (20) | To validate the diagnostic accuracy of grayscale IVUS, IB-IVUS, and OCT in characterising plaque types | 128 diseased segments obtained from 42 coronary arteries from 17 human cadavers were analysed |
|
| Rieber et al. (28) | To compare the diagnostic accuracy of OCT and IVUS in characterising plaque composition using histology are the reference standard | Histological sections from 17 coronary arteries assessed by IVUS and OCT were taken and divided into 4 quadrants (323 quadrants were included in the analysis) |
|
| Kume et al. (29) | To compare the efficacy of OCT and IVUS in assessing plaque types using histology as a gold standard | 166 sections from 108 coronary arterial segments obtained from 40 human cadaveric hearts were included in the study |
|
| Manfrini et al. (92) | To assess the efficacy of OCT in identifying plaque morphology | 68 histological cross-sections assessed by OCT were included in the study |
|
| Gruslova et al. (46) | To assess the accuracy of core labs in identifying plaque components and phenotypes in OCT images using histology as a reference standard | 51 OCT sequences obtained from 43 human hearts were provided to 7 core labs and their estimations were compared with reference to ex-vivo histology |
|
| Plaque micro-characteristics and thrombus | |||
| Tearney et al. (39) | To investigate the efficacy of OCT in identifying macrophages in fibrous caps using the standard deviation of the OCT signal intensity | OCT images portraying 26 lipid-rich atherosclerotic plaques (19 located in the aorta and 7 in carotid bulbs) from 17 cadavers were analysed |
|
| Phipps et al. (41) | To test the performance of OCT in detecting macrophages in the entire plaque | 1,559 OCT frames obtained from 14 human coronary arteries from 10 hearts were co-registered with histological cross-sections |
|
| Di Vito et al. (40) | To examine the capability of OCT in identifying macrophages in the entire plaque | 43 histological and OCT sections from 18 atherosclerotic plaques and 25 matched sections from non-diseased segment were included |
|
| Katayama et al. (43) | To examine the performance of OCT in detecting cholesterol crystals using histology as reference standard | Coronary segments (n = 45) with length 10–20 mm were assessed by OCT and its estimations were compared to histology |
|
| Jinnouchi et al. (44) | To assess the efficacy of OCT in detecting cholesterol crystals | 559 OCT frames from 45 autopsy cases were co-registered with histology; out of these 117 sections showed a necrotic core with cholesterol clefts |
|
| Kume et al. (45) | To assess the feasibility of time-domain OCT for detecting neo-vessels | 55 coronary plaques from 31 human cadavers were imaged by time domain OCT and the OCT frames were matched with histology |
|
| Shimokado et al. (93) | To assess the value of OCT in identifying healed coronary plaques | 144 OCT sections portaying diseased vessels (≥50% stenosis) were co-registered with histology; 30 were employed to define morphological features of healed plaques in histology and the remaining for testing |
|
| Kume et al. (94) | To test the efficacy of OCT in detecting coronary thrombi | 108 segments with length 5 cm from the proximal epicardial coronary arteries obtained from 40 human cadavers were assessed by OCT and the obtained images were matched with histology |
|
| Eriksen et al. (95) | To assess the value of OCT in characterizing thrombus type classified according to erythrocyte content and age | 42 aspirates containing thrombus from 66 STEMI patients were analysed |
|
| Combined IVUS-OCT imaging | |||
| Goderie et al. (96) | To assess the efficacy of VH-IVUS, OCT and combined VH-IVUS and OCT imaging in detecting plaque types | 36 matched IVUS, OCT and histological sections from 9 vessels were included in the analysis |
|
| Fujii et al. (30) | To assess the efficacy of OCT, IVUS and the combined IVUS and OCT imaging in identifying TCFA | 685 plaques obtained from 165 coronary arteries from 65 human hearts were assessed by IVUS and OCT and the acquired images were matched with histology |
|
| Brown et al. (97) | To assess the efficacy of IVUS-VH, OCT imaging and their combination in detecting TCFA | 258 histological cross-sections from the coronary arteries of 14 hearts that were assessed by VH-IVUS and OCT were included in the study |
|
| Nakano et al. (21) | To assess the performance of OCT in recognizing plaque morphologies and examine the additive values of IB-IVUS in detecting vulnerable plaque | 360 cross-sectional images obtained from 14 autopsy hearts (27 coronary arteries) were assessed by OCT and IB-IVUS and co-registered to histology |
|
Histology studies assessing the efficacy of intravascular imaging modalities in characterizing plaque morphology using human histology data as reference standard.
AUC, Area under curve; FA, Fibroatheroma; IB-IVUS, Integrated backscatter IVUS; IVUS, Intravascular ultrasound; OCT, Optical coherence tomography; NIRS, Near Infra-Red Spectroscopy; PIT, Pathological intimal thickening; STEMI, ST-elevated myocardial infarction; TCFA, Thin-capped fibroatheroma; VH-IVUS, Virtual histology intravascular ultrasound.
To overcome the limitations of greyscale IVUS to assess plaque composition, processing of the amplitude and the frequency of the reflected IVUS has been proposed. Three different approaches have been introduced for the radiofrequency analysis of the IVUS data: virtual histology (VH)-IVUS that uses autoregressive models to classify tissue types, integrated backscatter (IB) analysis that applies fast Fourier transformation to process the IVUS data, and iMAP that also relies on the identification of 40 spectral features in IVUS using autoregressive modelling and their comparison against the IVUS data obtained from typical plaques (13).
Virtual histology intravascular ultrasound
VH-IVUS can differentiate four tissue types: necrotic core, fibrofatty, fibrous and calcific tissue that are colour-coded displayed (red, light green, green and red and white). The first studies assessing the efficacy of VH-IVUS to characterise plaque composition showed promising results (14, 15). The tissue distribution in VH-IVUS was used to define for the first time in vivo plaque phenotypes whose vulnerability was tested in subsequent prospective studies (16).
However, more recent histology studies in porcine models published over the last decade cast doubts about the efficacy of VH-IVUS in assessing tissue composition (10, 17). This was also confirmed in a study performed in hearts obtained from patients listed for transplantation (n = 642 matched cross sections) which showed that VH-IVUS has a high sensitivity (94%), but low specificity (53%) and positive predictive value (48%) in detecting necrotic core. Today this technology has been withdrawn and is not clinically available (18).
Integrated backscatter intravascular ultrasound analysis
Integrated backscatter IVUS (IB-IVUS) analysis is currently available only in Japan. Ex vivo validation of this approach has shown that IB-IVUS has high accuracy in detecting plaque composition (19). However, the study of Kawasaki et al. which included 42 coronary arteries from 17 cadavers studied both by IB-IVUS and OCT, showed that both approaches had high sensitivity and specificity in detecting tissue types, but OCT was superior to IB-IVUS (20). Moreover, a recent report including coronary arteries from 14 human autopsy hearts assessed both by OCT and IB-IVUS (360 sections) demonstrated that IB-IVUS had a weak positive predictive value of only 50% but a high negative predictive value of 98.2% in detecting thin cap fibroatheromas (TCFA). In this study, the positive and negative predictive values of OCT were 60.9% and 98.8% respectively. Combining IB-IVUS and OCT, the positive and negative predictive values increased to 100% and 97.7% (21). These findings highlight the additive value of combined imaging in assessing plaque phenotypes. The IB-IVUS have been incorporated in the combined IVUS-OCT system designed by Terumo that is expected to be introduced in the clinical practice in 2025 (22).
iMap
iMap has been validated in a single histology study showing that this approach is valuable in detecting tissue types (23). However, an in vivo study comparing iMAP-IVUS and IB-IVUS showed a weak agreement between the two approaches to characterise plaque composition (24). Today iMap is not clinically available.
Optical coherence tomography
OCT was introduced for the study of the coronary arteries by professor Fujimoto at the end of the last century (25). This modality has a higher resolution than IVUS allowing more detailed visualization of plaque morphology and lumen pathology than IVUS. The first extensive histology validation of OCT was reported in 2002 and included arterial segments (n = 357, 162 aortas, 105 carotids, and 90 coronary arteries) from 90 cadavers. The authors found that OCT enables accurate characterization of all plaque types with high sensitivity (≥95%for calcific plaque, ≥71% for fibrous, and ≥90% for lipid-rich plaques) and specificity (97% for calcific plaque, ≥97% for fibrous, and ≥90% for lipid-rich plaques respectively) (26). Three years later Jang et al. demonstrated the feasibility of OCT in vivo and underscored its potential to visualize different plaque phenotypes in patients with an acute and chronic coronary syndrome (27).
Since then several studies have compared and underscored the superiority of OCT over IVUS using histology as reference standard especially in the detection of the lipid compoent (Figure 3) (20, 21, 28–30).
Figure 3
Summary of the average performance of the imaging techniques that are currently available in clinical practice to assess plaque composition. The pie charts summarise the number of studies that tested the performance of each imaging modality in assessing plaque types. The blue colour indicates the studies that allowed measurement of the performance metrics of each modality while the red the studies that did not allow computation of the sensitivity, specificity, positive, negative predictive value, and accuracy for each modality.
In addition, Kume et al. demonstrated that OCT, in contrast to IVUS, can visualize vessel wall architecture and portray the intima, media, and adventitia layers in disease-free vessels but on the other hand, it is widely acknowledged that OCT can often fail to assess the entire plaque and measure the plaque burden in heavily diseased segments as it has limited signal penetration (1–2 mm within the plaque) (31)
Conversely, the high resolution of OCT has enabled for the first time in vivo assessment of plaque microfeatures that have been associated with increased vulnerability and could not be detected by IVUS. Numerous histology studies have shown that the vulnerable plaques that cause events have an increased plaque burden, a large necrotic core component that is covered by a thin fibrous cap, and is rich in macrophages, neovessels, and cholesterol crystals (32–35).
Kume et al. were the first to investigate the performance of OCT in measuring fibrous thickness. The authors included 102 arterial segments from 38 human cadaveric hearts and compared the estimations of OCT against histology. They found a high correlation (r = 0.90, p < 0.001) but also a significant bias and wide limits of agreement between OCT estimations and histology (24 ± 44 µm). In addition, the authors reported a relatively high inter (13 ± 41 μm) and intra-observer (20 ± 59 μm) variability which can affect the differentiation of thin cap from thick cap fibroatheromas (36). More recent studies have looked into the limitations of OCT to accurately measure cap thickness and showed that the poor definition of the proximal edge of the necrotic core, the presence of macrophages and calcific tissue, as well as deeply embedded lipid tissue can affect the accurate delineation of the fibrous cap thickness (37). This limitation was partially overcome by the design of commercially available software that can automatically detect the fibrous cap border and reproducibly report its thickness (38).
OCT is the only clinically available intravascular imaging modality that can provide information about vascular inflammation. This was demonstrated in the early days of OCT by Tearney et al. who focused on the quantification of the macrophage content in the fibrous cap covering fibroatheromas. In this pivotal study including matched histological and OCT cross-sections the authors showed that increased OCT signal intensity was strongly associated with macrophage density (r = 0.83, p < 0001) (39). Di Vito et al. few years later, provided further evidence about the value of OCT to identify macrophages and introduced a two-step algorithm for automated macrophages detection. The algorithm included a size filter of structures and an OCT signal intensity metric and was validated against histology in 43 cross sections; the authors found an excellent performance of this approach to identify macrophages (sensitivity and specificity of 100% and 96.8% respectively) (40). However these findings were not confirmed in a larger study including 1,599 matched histological and OCT images. The authors implemented an automated method to detect bright spots in the entire plaque and showed that only 57% of the bright spots corresponded to macrophage accumulation in histology (other causes of bright spots in OCT included fibrous tissue, the interfaces between calcium and fibrous tissue, calcium and lipid deposits and fibrous caps and lipid tissue). Another interesting finding of this analysis was the fact that the macrophages in histology often appear as dark spots in OCT. Nevertheless, when analysis focused on the fibrous caps, they demonstrated a high accuracy of the modality with 94.3% of the bright spots detected by the algorithm corresponding to the presence of macrophages (41). Irrespective of these results the presence of macrophages in OCT seems to provide useful prognostic information as shown in the CLIMA study where inflamed plaques were associated with a higher rate of death or myocardial infarction (42).
Cholesterol crystals appear to play an important role in the biology of vulnerable plaques and studies have shown that they can contribute to their destabilization (35). In OCT, cholesterol crystals appear as thin, linear regions of high intensity (Figure 1). Two studies have examined the efficacy of OCT in detecting cholesterol crystals; the first included 45 matched histological and OCT cross-sections and showed that OCT was capable of correctly identifying these micro-structures with a moderate sensitivity but high specificity (68% and 92% respectively) (43). The second, was a much larger study including 559 matched OCT and histology sections; in this report a cholesterol crystal was defined as linear discrete high-intensity signal within the plaque with sharp borders that was adjacent to low/intermediate intensity tissue. Using this definition, the sensitivity of OCT was low, but the specificity was excellent (25.6% and 100% respectively) for detecting cholesterol crystals. The presence of multiple crystals and the morphological features of adjacent tissues and in particular an overlying fibrous cap were associated with a better accuracy of OCT to identify these plaques (44).
It has been speculated that OCT with its high resolution will be able to identify neo-vessels however, there is limited evidence about its efficacy in identifying these features. In a small histology study of 55 coronary plaques time-domain, OCT was able to detect neovascularization with a moderate sensitivity and specificity of 52% and 68%, respectively (45). There is no data today about the efficacy of frequency domain OCT which has a higher penetration than time domain OCT and is likely to have a better performance in assessing plaque pathology.
Most recently, Gruslova et al. examined the accuracy of seven OCT Core Labs in identifying plaque phenotypes and components. The authors demonstrated an overall moderate agreement between the core labs in assessing plaque features (mean kappa:0.67 ± 0.07); the core labs performed well in identifying fibrotic and calcific plaques, but they had a moderate performance in detecting thick cap fibroatheromas. A weak overall performance was noted between core lab estimations and histology for plaque features associated with increased vulnerability such as lipid tissue, necrotic core, TCFA, macrophages, and calcific nodules (46).
Summarizing the above, it is apparent that OCT is superior to IVUS in assessing plaque composition and biology, but it has inherent limitations in identifying all the plaque features related to increased vulnerability (Figures 2–3; Table 1). To overcomes these limitations polarization-sensitive OCT (PS-OCT) which allows assessment of the polarization state of the reflected OCT signal was proposed to better characterize atherosclerotic plaque components (47). The birefringence and depolarization measurements obtained by PS-OCT seem to provide incremental information about tissue types; however, the added value of this technique over conventional OCT in detecting vulnerable plaques has not been tested yet.
Near infrared spectroscopy
Near-infrared spectroscopy (NIRS) has extensively been used in chemistry to identify organic substances. It relies on the fact that different molecules can absorb and scatter the NIR light at different intensities and wavelengths. In the study of atherosclerosis, NIRS was used for the first time by Cassis and Lodder to assess plaque composition in rabbits (48), while the first application of this modality in humans was 3 years later by Dempsey et al. who tested its feasibility in detecting lipid tissue in carotids (49).
Moreno et al. provided additional evidence about the efficacy of NIRS to detect the presence of lipid tissue and vascular inflammation in human aortas whereas the first appropriately powered study that examined the value of NIRS to assess plaque composition in the coronary arteries was conducted by Gardner et al. and included coronary segments from 84 autopsy hearts (50, 51). The authors used the first 33 to refine the performance of NIRS to detect necrotic core plaques while the remaining 51 were used to validate it. They demonstrated that the block chemogram that summarizes the probability of the presence of lipid tissue in 2 mm segments was able to identify large necrotic cores—defined as those with circumferential extent >60° located in the superficial plaque with cap thickness <450 μm—with an area under the curve of 0.80 (95% CI: 0.76–0.85) (51, 52).
A subsequent analysis of thise data focusing on the performance of NIRS to characterise plaque phenotype demonstrated a low sensitivity but high specificity of NIRS to identify the presence of fibroatheromas that was attributed to the limited efficacy of the modality in detecting small necrotic cores, while the false positive NIRS estimations were attributed to the lipid component seen in lesions classified as pathological intimal thickening (53). Similar findings were seen in the study of Puri et al. which showed that NIRS was able to detect fibroatheromas with a moderate accuracy (c-index: 0.71) that increased to 0.80 when NIRS was combined with the information provided by IVUS (54). Finally, Inaba et al. explored the efficacy of NIRS in detecting TCFA and showed that a maximum lipid core burden index in a 4 mm segment ≥323—which indicates the fraction of pixels over 1,000 that corresponds to lipid tissue in a 4 mm segment with the largest lipid component—had an excellent accuracy in detecting this phenotype (AUC: 0.84) (54).
Summarizing the findings of these studies, it is apparent that NIRS has a high diagnostic accuracy in identifying lipid tissue; however, this modality cannot visualize the lumen and vessel wall, quantify the plaque burden, and provide depth information about the location of the lipid tissue in the plaque (Figure 3; Table 2). To overcome these limitations NIRS has been combined with an IVUS probe (TC Imaging Systemâ„¢ and Makoto Intravascular Imaging Systemâ„¢, Infraredx) in a hybrid NIRS-IVUS system; this prototype can assess lumen morphology and atheroma burden and in a recent histology study it has been shown that the circumferential location of the lipid tissue given by NIRS, and the pixel intensity of the plaque provided on IVUS allows accurate estimation of the lipid tissue distribution in the plaque (55).
Table 2
| Study | Objectives | Sample size | Results |
|---|---|---|---|
| NIRS | |||
| Moreno et al. (50) | To assess the efficacy of NIRS in detecting vulnerable plaque features and in particular lipid pools, atheromas with a fibrous cap thickness <65 µm and inflammatory cells | 199 samples from 5 human aortas were assessed by NIRS and matched with histology |
|
| Gardner et al. (51) | To assess the efficacy of NIRS in detecting lipid-rich plaques in coronary arteries of human cadavers | 212 coronary segments from 84 autopsied human hearts were assessed by NIRS; 33 hearts were used to refine the performance of NIRS and the remaining to evaluate its accuracy |
|
| Kang et al. (53) | To assess the ability of grayscale IVUS and NIRS to detect FAs | 1,943 histological cross-sections from 103 human coronary arteries from 56 autopsied hearts were matched with NIRS and IVUS imaging data |
|
| Puri et al. (54) | To test the performance of IVUS-derived plaque features and of NIRS in assessing plaque phenotype | 106 lesions detected in 116 human coronary arteries of 51 autopsied hearts were assessed by NIRS and IVUS included in the study |
|
| Inaba et al. (98) | To investigate the efficacy of IVUS and NIRS in characterizing TCFA lesions | 271 atherosclerotic lesions from 107 human coronary arteries derived from 54 autopsy hearts were imaged with NIRS-IVUS and matched with histology |
|
| NIRF imaging | |||
| Albaghdadi et al. (62) | To characterize plaque components associated with positive NIRAF signal | 15 human carotid endarterectomy specimens were imaged using fluorescence reflectance imaging and compared with histology |
|
| Kunio et al. (63) | To identify coronary plaque features associated with autofluoresence | Ex-vivo OCT-NIRAF was used to assess the coronary arteries of 23 fresh human cadavers |
|
| FLIm imaging | |||
| Fatakdawala et al. (66) | To evaluate the efficacy of combined FLIm and IVUS in detecting plaque morphology | Co-registered FLIm and IVUS data (n = 87 cross-sections) from 16 coronary arteries were correlated with histology |
|
Efficacy of invasive imaging modalities that provide an assessment of the biochemical composition of the plaque and of plaque biology in characterizing plaques characteristics using human histology data as reference standard.
AUC, area under curve; FA, fibroatheroma; FLIm, fluorescence lifetime imaging microscopy; IB, integrated backscatter; IVUS, intravascular ultrasound; LCBI, lipid core burden index; LDL, Low density lipoprotein; maxLCBI4 mm, Maximum LCBI in 4 mm segment; NIRS, near infra-red spectroscopy; NIRAF, near-infrared autofluorescence; OCT, optical coherence tomography; TCFA, thin capsule fibroatheroma.
More recently a hybrid OCT-NIRS probe was introduced that has undergone a first in-man study (56). Both systems have FDA approval for the detection of patients at risk of suffering MACE.
Near-infrared fluorescence imaging
Near-infrared fluorescence imaging (NIRF) has emerged as a translational intravascular modality for assessing plaque pathobiology. Imaging relies on the injection of specialized imaging agents which can bind molecules associated with specific biological processes and can fluoresce after being irradiated with NIR light.
Several animal studies have provided unique insights into the efficacy of this modality in assessing plaque activity. Today it is known that NIRF can detect, depending on the injected marker, macrophages accumulation, ICAM-1 an unpolymerized type I collagen, protease activity, and fibrin following stent implantation (57–59). Moreover, the study of Aikawa et al. underscored the value of NIRF to detect osteogenesis in mice using the activatable marker OsteoSense750 and reported a link between vascular inflammation and osteogenic activity in human plaques obtained following carotid endarterectomy (60). In addition, the BRIGHT-CEA study involving human specimens from carotid endarterectomy has shown that NIRF imaging, after injection of indocyanine green can detect an impaired endothelial integrity, including disrupted fibrous caps, areas of neovascularization, macrophages, lipid tissue, and intraplaque haemorrhages (57).
The first-in-man study examining the feasibility of NIRF imaging used a hybrid OCT-NIRF catheter and demonstrated that some plaques have the ability to auto fluoresce (NIRAF) without the need to inject activatable markers (61). Recent histology studies have provided further insights into the phenomenon with consistent results. The study of Albaghdadi et al., which included 15 human carotid endarterectomy specimens, demonstrated that NIRAF was associated with intraplaque haemorrhage (r = 0.48, P = 0.043) and lipid—specifically insoluble lipid or ceroid (r = 0.53, P = 0.023) (62). Similar were the findings of another study from the same research group that included coronary arteries from 31 fresh human donated hearts which showed that autofluorescence was associated with the presence of intraplaque haemorrhage and insoluble lipid or ceroid and that the association was stronger between autofluorescence and ceroid than intraplaque haemorrhage (63). The NIRF studies highlighted are summarised in Table 2.
NIRF has been combined with IVUS or OCT catheters in hybrid intravascular systems that are expected to enable anatomical and biological characterization of coronary atheroma, Canon Inc., Tokyo, Japan has invested in the commercialization of NIRF-OCT imaging which is anticipated to become clinically available in the following years.
Fluorescence lifetime imaging
Fluorescence lifetime imaging (FLIm) has been introduced to assess the biochemical composition of the superficial plaque. Imaging with this modality relies on the fact that different molecules can fluoresce for a specific time period after being irradiated with NIR light. Animal studies confirmed that measurement of the fluorescence time allows assessment of plaque composition and vascular inflammation (64, 65).
The potential of FLIm imaging is also supported by histology studies in human cadaveric hearts. In the study by Fatakdawala et al., combined IVUS and FLIm were used to characterise plaque morphology in 87 histological sections from 16 human coronary arteries; the authors showed that FLIm imaging had a superior sensitivity, specificity, and accuracy in assessing plaque phenotypes than standalone IVUS (70%, 98, 88% vs. 45%, 94% and 62% respectively). Combined FLIm-IVUS imaging outperformed standalone imaging in assessing plaque morphology (sensitivity 89%, specificity 99%, and accyracy 89%, respectively) (Table 2) (66). These results were also confirmed by a histology study including 47 segments obtained from human hearts that were imaged by a multimodal FLIm-OCT system. FLIm-OCT imaging was able to accurately detect 89.4% of the plaques underscoring the potential of hybrid-FLIm based imaging to assess plaque phenotypes (67).
In line with these findings a recent report including 32 human coronary artery segments assessed by combined IVUS-FLIm showed that FLIm was capable of accurately detecting superficial calcium (ROC-AUC: 0.90) and macrophages with high accuracy (ROC-AUC: 0.94) (68). The efficacy of FLIm to detect vascular inflammation was also confirmed by the study of Rico-Jimenez et al. that included 80 fresh post-mortem coronary segments from 23 autopsy hearts and showed that FLIm imaging was very accurate in identifying macrophages in the superficial plaque with an accuracy of 91.5% (69). The relevant studies of FLIm are summarised in Table 2.
FLIm imaging has been combined with OCT in a hybrid multimodality imaging probe developed by the Dotter Inc Seoul Korea that has been recently tested in clinical practice (NCT04835467). There is also a combined IVUS-FLIm catheter system that has an external diameter of 3.7Fr and is pulled back at a maximum speed of 4 mm/s. Imaging with this system requires blood clearance with bolus flushing; therefore, the maximum length that can be studied with this system is rather limiting. This constraint as well as the large diameter of the catheter has not enabled its application in the clinical arena (70).
Intravascular photoacoustic imaging
Intravascular photoacoustic (IVPA) imaging relies on the processing of the acoustic signal that is produced after the thermal expansion of molecules that have been irradiated with laser-light. In contrast to the NIRS, NIRF, and FLIm, IVPA provides depth information of tissue distribution by measuring the time interval between tissue irradiation and the IVPA signal.
Several experimental and animal studies have demonstrated the potential of IVPA to detect lipid tissue, collagen and metallic struts, as well as vascular inflammation and endothelial integrity when imaging is performed after injection of specific agents that are able to bind molecules that regulate plaque biology (71–75).
There is limited evidence about the performance of IVPA to characterize plaque morphology using ex vivo human data as reference standard. Reports involving a single coronary artery have shown the feasibility of this modality to detect lipid tissue (76), while Arabul et al. has shown that IVPA can identify intraplaque haemorrhages in atherosclerotic carotid plaques obtained following endarterectomy (77).
IVPA has been combined with IVUS imaging in hybrid IVPA-IVUS systems that enables evaluation of lumen and plaque dimensions and characterization of its composition. Several prototypes have been presented over the last few years for combined IVPA-IVUS imaging, however none of them has reached the clinical practice (78, 79). Kaminari Medical B.V., Rotterdam Netherlands is a recently developed company that aims to overcome limitations of previous revisions and design an hybrid IVPA-IVUS catheter for clinical applications. (https://kaminarimedical.com).
Discussion
From the early days of intravascular imaging, histology-based studies have been used to test the performance of existing and emerging modalities in evaluating vessel wall pathology and appreciate their potential in the clinical practice and research. These studies by identifying the advantages and limitations of each modality have helped in the evolution of intravascular imaging and guide the development of novel approaches that will outperform the existing techniques.
Today it is acknowledged that none of the available modalities is able to provide a complete and detailed visualization of plaque pathology. Therefore, there is a trend these days to design hybrid intravascular imaging systems that will incorporate two different imaging probes with complementary strengths for more detailed characterization of plaque pathobiology. The combined IVUS-OCT system as well as the NIRS-IVUS, OCT-NIRS, OCT-NIRF, FLIm-OCT and IVPA-IVUS are typical examples (34, 80, 81).
Preliminary validations studies of these systems using histology as reference standard have provided proof of the consensus showing that these approaches outperform standalone intravascular imaging systems in assessing plaque types (Figure 4) (55, 82). Histology is the gold standard for assessing plaque composition, however, the obvious requirement for intact coronary vessels to be used in these studies limits validation to model systems only, all of which have their drawbacks. Firstly, different vascular beds have different characteristics; for example, the carotid vessels have different elastic and smooth muscle composition to coronary vessels. In addition, cadaveric analysis from anatomy departments is compromised by their prior fixation and the fresh vessels from explanted recipient hearts or even post- mortem are compromised due to the extended period prior to sampling.
Figure 4
Panorama of hybrid intravascular imaging modalities and the corresponding histology. (Ai) An OCT-NIRF frame obtained after indocyanine green (ICG) injection showing increased uptake at (red arrowhead) in a lesion with intimal and medial calcification (yellow arrowheads) that was also confirmed by the corresponding fluorescence microscopy image (Aii). (Bi) NIRF-IVUS image showcasing high ICG-concentrations (red box) spatially related to a lipid and infiltrated macrophages as seen in the corresponding Oil Red O (ORO)-stained (Bii; red dotted box) and CD68-stained histological section (Biii; red dotted box) respectively. (Ci) An OCT-FLIM imaging with increased 540-nm lifetime values that correspond to pathological intimal thickening as seen in Movat's pentachrome-stained histology (Cii; PIT) and macrophages accumulation (*) that were confirmed by CD68-stained histology (Ciii). (Di) FLIM-IVUS cross-section demonstrating the presence of lipid tissue detected by FLIm in a calcified plaque confirmed by IVUS and the corresponding histology section stained with Movat's pentachrome showing a mixed plaque (Dii). (Ei) IVPA-IVUS frame portaying a lipid-rich plaque indicated with red-orange overlay. The corresponding ORO-stained histology confirms a large necrotic core (Eii). Image (Bi–Biii) courtesy of Rauschendorfer et al. (10.1038/s44325-024-00016-8). Image (Ci–Ciii) courtesy of Li et al. (10.1117/1.JBO.27.7.076005). Image (Ai,Aii), (Di,Dii), (Ei,Eii) courtesy of Tufaro et al. (10.1016/j.jcin.2024.07.007).
Other limitations of the studies assessing the performance of standalone intravascular imaging modalities include the fact that: (1) they are not appropriate powered, (2) they don't have a specific primary endpoint, (3) they often include a small number of matched frames that do not allow us to draw safe conclusions, (4) the matching of the intravascular imaging and histology data can be challenging and affect the final results, and (5) the tissue shrinkage that occurs during histological preparation that does not allow us to accurately test the performance of intravascular imaging to quantify plaque burden and composition. Moreover, in most of the histology studies a single histological staining was used that does not enable a complete evaluation of plaque pathology and is likely to influence image interpretation. Finally, the reproducibility of the clinicians and the histopathologists who performed the analyses is not always reported even though it can influence the results (83, 84).
It is therefore essential to standardize analyses protocols and perform large prospective histopathological based studies that will be appropriately powered and will facilitate—using landmarks—the intravascular imaging and histology sections matching and will make use of multiplex immunohistochemistry and 3D based histology so as to appreciate the full potential of each modality to assess plaque pathology. This approach will allow us to better understand the potential of the existing catheters, identify their limitations, and design future prototypes that will combine multiple imaging probes to address the current clinical needs (i.e., optimal PCI planning and vulnerable plaque detection) and improve clinical outcomes.
These datasets can be also used to train and test the performance of deep learning (DL) classifiers that will allow fast, accurate and reproducible characterization of plaque phenotypes. Proof of concepts studies have highlighted the potential of DL methods in the analysis of intravascular imaging data (55, 85–87). However, the small number of histological sections included, the use of a single stain and limitations in the co-registration of intravascular imaging and histology have not allowed us to explore the full potential of DL in this setting. There is therefore an unmet need to generate large optimal intravascular-histological imaging data that will be stained with multiple stains enabling thorough assessment of plaque characteristics and use these to develop efficient DL solutions that will allow enhanced tissue characterization reliable assessment of plaque vulnerability and more accurate risk stratification.
This strategy may also be helpful in the optimization of the deep learning solutions that have been introduced to analyze computerized tomography coronary angiography (CTCA) data and unlock the full potential of CTCA in the study of atherosclerosis, enable more precise detection of vulnerable plaque, and quantification of the lumen and vessel dimensions that are essential in treatment planning (88–91).
Statements
Author contributions
NY: Conceptualization, Investigation, Writing – original draft, Writing – review & editing, Formal Analysis. ZK: Conceptualization, Writing – review & editing, Formal Analysis, Investigation. XH: Writing – review & editing. JL: Writing – review & editing. SM: Writing – review & editing. KM: Writing – review & editing. TZ: Writing – review & editing. HP: Resources, Writing – review & editing. PS: Writing – review & editing. HG-G: Writing – review & editing. YO: Writing – review & editing. SH: Writing – review & editing. SK: Writing – review & editing. AM: Writing – review & editing. AB: Writing – review & editing. CB: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing.
Funding
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Generative AI statement
The author(s) declare that no Generative AI was used in the creation of this manuscript.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1.
Meier B . His master’s art, Andreas Grüntzig’s approach to performing and teaching coronary angioplasty. EuroIntervention. (2017) 13(1):15–27. 10.4244/eijv13i1a2
2.
Yock PG Linker DT . Intravascular ultrasound. Looking below the surface of vascular disease. Circulation. (1990) 81(5):1715–8. 10.1161/01.cir.81.5.1715
3.
Vrints C Andreotti F Koskinas KC et al 2024 ESC guidelines for the management of chronic coronary syndromes. Eur Heart J. (2024). 10.1093/eurheartj/ehae177
4.
Stone GW Christiansen EH Ali ZA et al Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis. Lancet. (2024) 403(10429):824–37. 10.1016/S0140-6736(23)02454-6
5.
Giacoppo D Laudani C Occhipinti G et al Coronary angiography, intravascular ultrasound, and optical coherence tomography for guiding of percutaneous coronary intervention: a systematic review and network meta-analysis. Circulation. (2024) 149(14):1065–86. 10.1161/CIRCULATIONAHA.123.067583
6.
Baumbach A Bourantas CV Serruys PW Wijns W . The year in cardiology: coronary interventions. Eur Heart J. (2020) 41(3):394–405. 10.1093/eurheartj/ehz947
7.
Jebari-Benslaiman S Galicia-GarcÃa U Larrea-Sebal A et al Pathophysiology of atherosclerosis. Int J Mol Sci. (2022) 23(6). 10.3390/ijms23063346
8.
Gussenhoven EJ Essed CE Lancee CT et al Arterial wall characteristics determined by intravascular ultrasound imaging: an in vitro study. J Am Coll Cardiol. (1989) 14(4):947–52. 10.1016/0735-1097(89)90471-3
9.
Mintz GS Nissen SE Anderson WD et al American college of cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American college of cardiology task force on clinical expert consensus documents. J Am Coll Cardiol. (2001) 37(5):1478–92. 10.1016/s0735-1097(01)01175-5
10.
Granada JF Wallace-Bradley D Win HK et al In vivo plaque characterization using intravascular ultrasound-virtual histology in a porcine model of complex coronary lesions. Arterioscler Thromb Vasc Biol. (2007) 27(2):387–93. 10.1161/01.ATV.0000253907.51681.0e
11.
Bruining N Verheye S Knaapen M et al Three-dimensional and quantitative analysis of atherosclerotic plaque composition by automated differential echogenicity. Catheter Cardiovasc Interv. (2007) 70(7):968–78. 10.1002/ccd.21310
12.
Pu J Mintz GS Biro S et al Insights into echo-attenuated plaques, echolucent plaques, and plaques with spotty calcification: novel findings from comparisons among intravascular ultrasound, near-infrared spectroscopy, and pathological histology in 2,294 human coronary artery segments. J Am Coll Cardiol. (2014) 63(21):2220–33. 10.1016/j.jacc.2014.02.576
13.
Mehta SK McCrary JR Frutkin AD Dolla WJ Marso SP . Intravascular ultrasound radiofrequency analysis of coronary atherosclerosis: an emerging technology for the assessment of vulnerable plaque. Eur Heart J. (2007) 28(11):1283–8. 10.1093/eurheartj/ehm112
14.
Nair A Kuban BD Tuzcu EM Schoenhagen P Nissen SE Vince DG . Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation. (2002) 106(17):2200–6. 10.1161/01.CIR.0000035654.18341.5E
15.
Nair A Margolis MP Kuban BD Vince DG . Automated coronary plaque characterisation with intravascular ultrasound backscatter: ex vivo validation. EuroIntervention. (2007) 3(1):113–20.
16.
Garcia-Garcia HM Mintz GS Lerman A et al Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting. EuroIntervention. (2009) 5(2):177–89. 10.4244/eijv5i2a29
17.
Thim T Hagensen MK Wallace-Bradley D et al Unreliable assessment of necrotic core by virtual histology intravascular ultrasound in porcine coronary artery disease. Circ Cardiovasc Imaging. (2010) 3(4):384–91. 10.1161/CIRCIMAGING.109.919357
18.
Brugaletta S Cola C Martin-Yuste V et al Qualitative and quantitative accuracy of ultrasound-based virtual histology for detection of necrotic core in human coronary arteries. Int J Cardiovasc Imaging. (2014) 30(3):469–76. 10.1007/s10554-014-0372-5
19.
Kawasaki M Takatsu H Noda T et al In vivo quantitative tissue characterization of human coronary arterial plaques by use of integrated backscatter intravascular ultrasound and comparison with angioscopic findings. Circulation. (2002) 105(21):2487–92. 10.1161/01.cir.0000017200.47342.10
20.
Kawasaki M Bouma BE Bressner J et al Diagnostic accuracy of optical coherence tomography and integrated backscatter intravascular ultrasound images for tissue characterization of human coronary plaques. J Am Coll Cardiol. (2006) 48(1):81–8. 10.1016/j.jacc.2006.02.062
21.
Nakano M Yahagi K Yamamoto H et al Additive value of integrated backscatter IVUS for detection of vulnerable plaque by optical frequency domain imaging: an ex vivo autopsy study of human coronary arteries. JACC Cardiovasc Imaging. (2016) 9(2):163–72. 10.1016/j.jcmg.2015.07.011
22.
Ono M Kawashima H Hara H et al Advances in IVUS/OCT and future clinical perspective of novel hybrid catheter system in coronary imaging. Front Cardiovasc Med. (2020) 7:119. 10.3389/fcvm.2020.00119
23.
Sathyanarayana S Carlier S Li W Thomas L . Characterisation of atherosclerotic plaque by spectral similarity of radiofrequency intravascular ultrasound signals. EuroIntervention. (2009) 5(1):133–9. 10.4244/eijv5i1a21
24.
Yamada R Okura H Kume T et al A comparison between 40 MHz intravascular ultrasound iMap imaging system and integrated backscatter intravascular ultrasound. J Cardiol. (2013) 61(2):149–54. 10.1016/j.jjcc.2012.10.008
25.
Brezinski ME Tearney GJ Bouma BE et al Imaging of coronary artery microstructure (in vitro) with optical coherence tomography. Am J Cardiol. (1996) 77(1):92–3. 10.1016/s0002-9149(97)89143-6
26.
Yabushita H Bouma BE Houser SL et al Characterization of human atherosclerosis by optical coherence tomography. Circulation. (2002) 106(13):1640–5. 10.1161/01.cir.0000029927.92825.f6
27.
Jang IK Tearney GJ MacNeill B et al In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation. (2005) 111(12):1551–5. 10.1161/01.CIR.0000159354.43778.69
28.
Rieber J Meissner O Babaryka G et al Diagnostic accuracy of optical coherence tomography and intravascular ultrasound for the detection and characterization of atherosclerotic plaque composition in ex-vivo coronary specimens: a comparison with histology. Coron Artery Dis. (2006) 17(5):425–30. 10.1097/00019501-200608000-00005
29.
Kume T Akasaka T Kawamoto T et al Assessment of coronary arterial plaque by optical coherence tomography. Am J Cardiol. (2006) 97(8):1172–5. 10.1016/j.amjcard.2005.11.035
30.
Fujii K Hao H Shibuya M et al Accuracy of OCT, grayscale IVUS, and their combination for the diagnosis of coronary TCFA: an ex vivo validation study. JACC Cardiovasc Imaging. (2015) 8(4):451–60. 10.1016/j.jcmg.2014.10.015
31.
Kume T Akasaka T Kawamoto T et al Assessment of coronary intima–media thickness by optical coherence tomography: comparison with intravascular ultrasound. Circ J. (2005) 69(8):903–7. 10.1253/circj.69.903
32.
Burke AP Farb A Malcom GT Liang YH Smialek J Virmani R . Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. (1997) 336(18):1276–82. 10.1056/NEJM199705013361802
33.
Virmani R Kolodgie FD Burke AP et al Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol. (2005) 25(10):2054–61. 10.1161/01.ATV.0000178991.71605.18
34.
Bourantas CV Garcia-Garcia HM Diletti R Muramatsu T Serruys PW . Early detection and invasive passivation of future culprit lesions: a future potential or an unrealistic pursuit of chimeras?Am Heart J. (2013) 165(6):869–881.e4. 10.1016/j.ahj.2013.02.015
35.
Abela GS Aziz K Vedre A Pathak DR Talbott JD Dejong J . Effect of cholesterol crystals on plaques and intima in arteries of patients with acute coronary and cerebrovascular syndromes. Am J Cardiol. (2009) 103(7):959–68. 10.1016/j.amjcard.2008.12.019
36.
Kume T Akasaka T Kawamoto T et al Measurement of the thickness of the fibrous cap by optical coherence tomography. Am Heart J. (2006) 152(4):755.e1–4. 10.1016/j.ahj.2006.06.030
37.
Kini AS Vengrenyuk Y Yoshimura T et al Fibrous cap thickness by optical coherence tomography in vivo. J Am Coll Cardiol. (2017) 69(6):644–57. 10.1016/j.jacc.2016.10.028
38.
Radu MD Yamaji K Garcia-Garcia HM et al Variability in the measurement of minimum fibrous cap thickness and reproducibility of fibroatheroma classification by optical coherence tomography using manual versus semi-automatic assessment. EuroIntervention. (2016) 12(8):e987–97. 10.4244/EIJV12I8A162
39.
Tearney GJ Yabushita H Houser SL et al Quantification of macrophage content in atherosclerotic plaques by optical coherence tomography. Circulation. (2003) 107(1):113–9. 10.1161/01.cir.0000044384.41037.43
40.
Di Vito L Agozzino M Marco V et al Identification and quantification of macrophage presence in coronary atherosclerotic plaques by optical coherence tomography. Eur Heart J Cardiovasc Imaging. (2015) 16(7):807–13. 10.1093/ehjci/jeu307
41.
Phipps JE Vela D Hoyt T et al Macrophages and intravascular OCT bright spots: a quantitative study. JACC Cardiovasc Imaging. (2015) 8(1):63–72. 10.1016/j.jcmg.2014.07.027
42.
Prati F Romagnoli E Gatto L et al Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study. Eur Heart J. (2020) 41(3):383–91. 10.1093/eurheartj/ehz520
43.
Katayama Y Tanaka A Taruya A et al Feasibility and clinical significance of in vivo cholesterol crystal detection using optical coherence tomography. Arterioscler Thromb Vasc Biol. (2020) 40(1):220–9. 10.1161/ATVBAHA.119.312934
44.
Jinnouchi H Sato Y Torii S et al Detection of cholesterol crystals by optical coherence tomography. EuroIntervention. (2020) 16(5):395–403. 10.4244/EIJ-D-20-00202
45.
Kume T Okura H Yamada R et al Detection of plaque neovascularization by optical coherence tomography: ex vivo feasibility study and in vivo observation in patients with angina pectoris. J Invasive Cardiol. (2016) 28(1):17–22.
46.
Gruslova AB Singh S Hoyt T et al Accuracy of OCT core labs in identifying vulnerable plaque. JACC Cardiovasc Imaging. (2024) 17(4):448–50. 10.1016/j.jcmg.2023.10.005
47.
Otsuka K Villiger M Nadkarni SK Bouma BE . Intravascular polarimetry: clinical translation and future applications of catheter-based polarization sensitive optical frequency domain imaging. Front Cardiovasc Med. (2020) 7:146. 10.3389/fcvm.2020.00146
48.
Cassis LA Lodder RA . Near-IR imaging of atheromas in living arterial tissue. Anal Chem. (1993) 65(9):1247–56. 10.1021/ac00057a023
49.
Dempsey RJ Davis DG Buice RG Lodder RA . Biological and medical applications of near-infrared spectrometry. Appl Spectrosc. (1996) 50(2):18A–34A. 10.1366/0003702963906537
50.
Moreno PR Lodder RA Purushothaman KR Charash WE O'Connor WN Muller JE . Detection of lipid pool, thin fibrous cap, and inflammatory cells in human aortic atherosclerotic plaques by near-infrared spectroscopy. Circulation. (2002) 105(8):923–7. 10.1161/hc0802.104291
51.
Gardner CM Tan H Hull EL et al Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system. JACC Cardiovasc Imaging. (2008) 1(5):638–48. 10.1016/j.jcmg.2008.06.001
52.
Schlett CL Maurovich-Horvat P Ferencik M et al Histogram analysis of lipid-core plaques in coronary computed tomographic angiography: ex vivo validation against histology. Invest Radiol. (2013) 48(9):646–53. 10.1097/RLI.0b013e31828fdf9f
53.
Kang SJ Mintz GS Pu J et al Combined IVUS and NIRS detection of fibroatheromas: histopathological validation in human coronary arteries. JACC Cardiovasc Imaging. (2015) 8(2):184–94. 10.1016/j.jcmg.2014.09.021
54.
Puri R Madder RD Madden SP et al Near-infrared spectroscopy enhances intravascular ultrasound assessment of vulnerable coronary plaque: a combined pathological and in vivo study. Arterioscler Thromb Vasc Biol. (2015) 35(11):2423–31. 10.1161/ATVBAHA.115.306118
55.
Bajaj R Eggermont J Grainger SJ et al Machine learning for atherosclerotic tissue component classification in combined near-infrared spectroscopy intravascular ultrasound imaging: validation against histology. Atherosclerosis. (2022) 345:15–25. 10.1016/j.atherosclerosis.2022.01.021
56.
Ali ZA Dager A Zuniga M et al First-in-human experience with a novel multimodality DeepOCT-NIRS intracoronary imaging system. J Soc Cardiovasc Angiogr Interv. (2024) 3(4):101344. 10.1016/j.jscai.2024.101344
57.
Verjans JW Osborn EA Ughi GJ et al Targeted near-infrared fluorescence imaging of atherosclerosis: clinical and intracoronary evaluation of indocyanine green. JACC Cardiovasc Imaging. (2016) 9(9):1087–95. 10.1016/j.jcmg.2016.01.034
58.
Hara T Ughi GJ McCarthy JR et al Intravascular fibrin molecular imaging improves the detection of unhealed stents assessed by optical coherence tomography in vivo. Eur Heart J. (2017) 38(6):447–55. 10.1093/eurheartj/ehv677
59.
Khraishah H Jaffer FA . Intravascular molecular imaging: near-infrared fluorescence as a new frontier. Front Cardiovasc Med. (2020) 7:587100. 10.3389/fcvm.2020.587100
60.
Aikawa E Nahrendorf M Figueiredo JL et al Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation. (2007) 116(24):2841–50. 10.1161/CIRCULATIONAHA.107.732867
61.
Ughi GJ Wang H Gerbaud E et al Clinical characterization of coronary atherosclerosis with dual-modality OCT and near-infrared autofluorescence imaging. JACC Cardiovasc Imaging. (2016) 9(11):1304–14. 10.1016/j.jcmg.2015.11.020
62.
Albaghdadi MS Ikegami R Kassab MB et al Near-infrared autofluorescence in atherosclerosis associates with ceroid and is generated by oxidized lipid-induced oxidative stress. Arterioscler, Thromb, Vasc Biol. (2021) 41(7):e385–98. 10.1161/ATVBAHA.120.315612
63.
Kunio M Gardecki JA Watanabe K et al Histopathological correlation of near infrared autofluorescence in human cadaver coronary arteries. Atherosclerosis. (2022) 344:31–9. 10.1016/j.atherosclerosis.2022.01.012
64.
Marcu L Fang Q Jo JA et al In vivo detection of macrophages in a rabbit atherosclerotic model by time-resolved laser-induced fluorescence spectroscopy. Atherosclerosis. (2005) 181(2):295–303. 10.1016/j.atherosclerosis.2005.02.010
65.
Kim S Nam HS Lee MW et al Comprehensive assessment of high-risk plaques by dual-modal imaging catheter in coronary artery. JACC Basic Transl Sci. (2021) 6(12):948–60. 10.1016/j.jacbts.2021.10.005
66.
Fatakdawala H Gorpas D Bishop JW et al Fluorescence lifetime imaging combined with conventional intravascular ultrasound for enhanced assessment of atherosclerotic plaques: an ex vivo study in human coronary arteries. J Cardiovasc Transl Res. (2015) 8(4):253–63. 10.1007/s12265-015-9627-3
67.
Jo JA Park J Pande P et al Simultaneous morphological and biochemical endogenous optical imaging of atherosclerosis. Eur Heart J Cardiovasc Imaging. (2015) 16(8):910–8. 10.1093/ehjci/jev018
68.
Bec J Vela D Phipps JE et al Label-free visualization and quantification of biochemical markers of atherosclerotic plaque progression using intravascular fluorescence lifetime. JACC Cardiovasc Imaging. (2021) 14(9):1832–42. 10.1016/j.jcmg.2020.10.004
69.
Rico-Jimenez JJ Serafino MJ Shrestha S et al Automated detection of superficial macrophages in atherosclerotic plaques using autofluorescence lifetime imaging. Atherosclerosis. (2019) 285:120–7. 10.1016/j.atherosclerosis.2019.04.223
70.
Bec J Phipps JE Gorpas D et al In vivo label-free structural and biochemical imaging of coronary arteries using an integrated ultrasound and multispectral fluorescence lifetime catheter system. Sci Rep. (2017) 7(1):8960. 10.1038/s41598-017-08056-0
71.
Sethuraman S Amirian JH Litovsky SH Smalling RW Emelianov SY . Spectroscopic intravascular photoacoustic imaging to differentiate atherosclerotic plaques. Opt Express. (2008) 16(5):3362–7. 10.1364/oe.16.003362
72.
Su JL Wang B Emelianov SY . Photoacoustic imaging of coronary artery stents. Opt Express. (2009) 17(22):19894–901. 10.1364/OE.17.019894
73.
Zhang J Yang S Ji X Zhou Q Xing D . Characterization of lipid-rich aortic plaques by intravascular photoacoustic tomography: ex vivo and in vivo validation in a rabbit atherosclerosis model with histologic correlation. J Am Coll Cardiol. (2014) 64(4):385–90. 10.1016/j.jacc.2014.04.053
74.
Bui NQ Hlaing KK Lee YW Kang HW Oh J . Ex vivo detection of macrophages in atherosclerotic plaques using intravascular ultrasonic-photoacoustic imaging. Phys Med Biol. (2017) 62(2):501–16. 10.1088/1361-6560/aa4f6b
75.
Wang B Yantsen E Larson T et al Plasmonic intravascular photoacoustic imaging for detection of macrophages in atherosclerotic plaques. Nano Lett. (2009) 9(6):2212–7. 10.1021/nl801852e
76.
Jansen K Wu M van der Steen AF van Soest G . Lipid detection in atherosclerotic human coronaries by spectroscopic intravascular photoacoustic imaging. Opt Express. (2013) 21(18):21472–84. 10.1364/OE.21.021472
77.
Arabul MU Heres M Rutten MC van Sambeek MR van de Vosse FN Lopata RG . Toward the detection of intraplaque hemorrhage in carotid artery lesions using photoacoustic imaging. J Biomed Opt. (2017) 22(4):41010. 10.1117/1.JBO.22.4.041010
78.
Hui J Cao Y Zhang Y et al Real-time intravascular photoacoustic-ultrasound imaging of lipid-laden plaque in human coronary artery at 16 frames per second. Sci Rep. (2017) 7(1):1417. 10.1038/s41598-017-01649-9
79.
Iskander-Rizk S Wu M Springeling G et al In vivo intravascular photoacoustic imaging of plaque lipid in coronary atherosclerosis. EuroIntervention. (2019) 15(5):452–6. 10.4244/EIJ-D-19-00318
80.
Bourantas CV Jaffer FA Gijsen FJ et al Hybrid intravascular imaging: recent advances, technical considerations, and current applications in the study of plaque pathophysiology. Eur Heart J. (2017) 38(6):400–12. 10.1093/eurheartj/ehw097
81.
Bajaj R Garcia-Garcia HM Courtney BK et al Multi-modality intravascular imaging for guiding coronary intervention and assessing coronary atheroma: the Novasight hybrid IVUS-OCT system. Minerva Cardiol Angiol. (2021) 69(6):655–70. 10.23736/S2724-5683.21.05532-0
82.
Li BH Leung AS Soong A et al Hybrid intravascular ultrasound and optical coherence tomography catheter for imaging of coronary atherosclerosis. Catheter Cardiovasc Interv. (2013) 81(3):494–507. 10.1002/ccd.24295
83.
Ford JC O'Rourke K Veinot JP Walley VM . Histologic estimation of coronary artery stenoses: reproducibility and the effect of training. Cardiovasc Pathol. (2000) 9(5):251–5. 10.1016/S1054-8807(00)00044-2
84.
Palmer ND Northridge D Lessells A McDicken WN Fox KA . In vitro analysis of coronary atheromatous lesions by intravascular ultrasound; reproducibility and histological correlation of lesion morphology. Eur Heart J. (1999) 20(23):1701–6. 10.1053/euhj.1999.1627
85.
Baruah V Zahedivash A Hoyt T et al Automated coronary plaque characterization with intravascular optical coherence tomography and smart-algorithm approach: virtual histology OCT. JACC Cardiovasc Imaging. (2020) 13(8):1848–50. 10.1016/j.jcmg.2020.02.022
86.
Shibutani H Fujii K Ueda D et al Automated classification of coronary atherosclerotic plaque in optical frequency domain imaging based on deep learning. Atherosclerosis. (2021) 328:100–5. 10.1016/j.atherosclerosis.2021.06.003
87.
Bajaj R Parasa R Broersen A et al Examination of the performance of machine learning-based automated coronary plaque characterization by NIRS-IVUS and OCT with histology. Eur Heart J Dig Health. (2025). In press.
88.
Ramasamy A Parasa R Sokooti H et al Computed tomography versus near-infrared spectroscopy for the assessment of coronary atherosclerosis. EuroIntervention. (2024) 20(23):e1465–75. 10.4244/EIJ-D-24-00096
89.
Ramasamy A Pugliese F Tanboga IH et al Head-to-head comparison of near-infrared spectroscopy-intravascular ultrasound and coronary computed tomography angiography in assessing atheroma characteristics. JACC Cardiovasc Imaging. (2024) 17(12):1507–10. 10.1016/j.jcmg.2024.07.005
90.
Ramasamy A Sokooti H Zhang X et al Novel near-infrared spectroscopy-intravascular ultrasound-based deep-learning methodology for accurate coronary computed tomography plaque quantification and characterization. Eur Heart J Open. (2023) 3(5):oead090. 10.1093/ehjopen/oead090
91.
Narula J Stuckey TD Nakazawa G et al Prospective deep learning-based quantitative assessment of coronary plaque by computed tomography angiography compared with intravascular ultrasound: the REVEALPLAQUE study. Eur Heart J Cardiovasc Imaging. (2024) 25(9):1287–95. 10.1093/ehjci/jeae115
92.
Manfrini O Mont E Leone O et al Sources of error and interpretation of plaque morphology by optical coherence tomography. Am J Cardiol. (2006) 98(2):156–9. 10.1016/j.amjcard.2006.01.097
93.
Shimokado A Matsuo Y Kubo T et al In vivo optical coherence tomography imaging and histopathology of healed coronary plaques. Atherosclerosis. (2018) 275:35–42. 10.1016/j.atherosclerosis.2018.05.025
94.
Kume T Akasaka T Kawamoto T et al Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol. (2006) 97(12):1713–7. 10.1016/j.amjcard.2006.01.031
95.
Eriksen E Herstad J Pertiwi KR et al Thrombus characteristics evaluated by acute optical coherence tomography in ST elevation myocardial infarction. PLoS One. (2022) 17(4):e0266634. 10.1371/journal.pone.0266634
96.
Goderie TPM van Soest G Garcia-Garcia HM et al Combined optical coherence tomography and intravascular ultrasound radio frequency data analysis for plaque characterization. Classification accuracy of human coronary plaques in vitro. Int J Cardiovasc Imaging. (2010) 26(8):843–50. 10.1007/s10554-010-9631-2
97.
Brown AJ Obaid DR Costopoulos C et al Direct comparison of virtual-histology intravascular ultrasound and optical coherence tomography imaging for identification of thin-cap fibroatheroma. Circ Cardiovasc Imaging. (2015) 8(10):e003487. 10.1161/CIRCIMAGING.115.003487
98.
Inaba S Mintz GS Burke AP et al Intravascular ultrasound and near-infrared spectroscopic characterization of thin-cap fibroatheroma. Am J Cardiol. (2017) 119(3):372–8. 10.1016/j.amjcard.2016.10.031
Summary
Keywords
intravascular ultrasound, optical coherence tomography, near-infrared spectroscopy, histology, hybrid intravascular imaging
Citation
Yap NAL, Khan Z, He X, Lee J-G, Maung S, Morgan KR, Zhou T, Precht H, Serruys PW, Garcia-Garcia HM, Onuma Y, Hynes S, Kelle S, Mathur A, Baumbach A and Bourantas CV (2025) What have we learnt from histology about the efficacy of coronary imaging modalities in assessing plaque composition?. Front. Cardiovasc. Med. 12:1507892. doi: 10.3389/fcvm.2025.1507892
Received
08 October 2024
Accepted
06 January 2025
Published
24 January 2025
Volume
12 - 2025
Edited by
Grigorios Korosoglou, GRN Klinik Weinheim, Germany
Reviewed by
Tatsuhiko Otsuka, Itabashi Chuo Medical Center, Japan
Hans Reiber, Medis Medical Imaging Systems bv, Netherlands
Updates
Copyright
© 2025 Yap, Khan, He, Lee, Maung, Morgan, Zhou, Precht, Serruys, Garcia-Garcia, Onuma, Hynes, Kelle, Mathur, Baumbach and Bourantas.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Christos V. Bourantas cbourantas@gmail.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.